Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

  • ComfluCOV Trial Group
  • , Rajeka Lazarus*
  • , Sarah Baos
  • , Heike Cappel-Porter
  • , Andrew Carson-Stevens
  • , Madeleine Clout
  • , Lucy Culliford
  • , Stevan R. Emmett
  • , Jonathan Garstang
  • , Lukuman Gbadamoshi
  • , Bassam Hallis
  • , Rosie A. Harris
  • , David Hutton
  • , Nick Jacobsen
  • , Katherine Joyce
  • , Rachel Kaminski
  • , Vincenzo Libri
  • , Alex Middleditch
  • , Liz McCullagh
  • , Ed Moran
  • Adrian Phillipson, Elizabeth Price, John Ryan, Russell Thirard, Rachel Todd, Matthew D. Snape, David Tucker, Rachel Lauren Williams, Jonathan S. Nguyen-Van-Tam, Adam Finn, Chris A. Rogers
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

133 Citations (Scopus)
16 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry